First 5 minutes of this weeks ABC’s Health Report with Dr Norman Swan and Tegan Taylor features discussions with John Rasko AO discussing the results of Cynata Therapeutics first demonstration of two year safety results in their clinical trial for Graft versus Host disease. The other stem cell therapy trials mentioned By John I believe are all using Cynata’s iPSCs also.
Next 18 months is going to see results and updates on all of these trials and should be very rewarding for Cynata.
https://www.abc.net.au/listen/programs/healthreport/3d-printing-heart-transplant/103904548?utm_content=link&utm_medium=content_shared
Ann: Investor Presentation, page-176
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $39.74M | |||
| Open | High | Low | Value | Volume |
| 22.0¢ | 22.5¢ | 22.0¢ | $29.06K | 131.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 951 | 22.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.0¢ | 10000 | 1 |
View Market Depth
| Last trade - 15.59pm 08/11/2024 (20 minute delay) ? |
| CYP (ASX) Chart |